Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Merck Loses Protection for Patent on Zocor
Midkine and multiple sclerosis.
Inter-hemispheric functional connectivity changes with corpus callosum morphology in multiple sclerosis.
TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
Neurological disorders in the Global Burden of Disease 2010 study.
Cognitive motor interference during walking in multiple sclerosis using an alternate letter alphabet task.
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
[Depression and neurological diseases].
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
The role of chromogranin B in an animal model of multiple sclerosis.
High in vitro immune reactivity to Escherichia coli in neuromyelitis optica patients is correlated with both neurological disabilities and elevated plasma lipopolysaccharide levels.
Non-contraceptive benefits of oral hormonal contraceptives.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Open Ring Sign Diagnostic of Multiple Sclerosis in the Emergency Department.
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
Human Umbilical Tissue-Derived Cells Promote Synapse Formation and Neurite Outgrowth via Thrombospondin Family Proteins.
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes.
Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model.
Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Microparticles: A New Perspective in Central Nervous System Disorders.
CBRAIN: a web-based, distributed computing platform for collaborative neuroimaging research.
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »